Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Prostate Cancer

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Prostate Cancer Paradigm Progresses, But Unanswered Questions Remain

Randy F. Sweis, MD, discusses recent progress and next steps in the prostate cancer paradigm.
Read More >>

FDA Grants Rucaparib Breakthrough Designation for mCRPC

Challenges Remain in Prostate Cancer Paradigm

Patient-Centered Focus Drives Growth at Virginia Urology

Personalized Medicine in Prostate Cancer: Now More Precise

Apalutamide Maintains Health-Related QoL in Nonmetastatic CRPC

View More Stories >>

View Conference Coverage

2018 State of the Science Summit on Hematologic Malignancies in Clayton

State of the Science Summit on GI Cancers in Newport Beach

2018 ESMO Congress

2018 State of the Science Summit on Hematologic Malignancies in Cleveland

2018 Lynn Sage Breast Cancer Symposium

Dr. Sweis on Sequencing of Therapies in Prostate Cancer

Dr. Daskivich Discusses Active Surveillance in Prostate Cancer

Dr. Sharma Discusses Immunotherapy in Prostate Cancer

Dr. Steinberg on the Management of Prostate Cancer

Dr. Stadler on Sequencing Therapies in Prostate Cancer

Dr. Daskivich on the Future Landscape of Prostate Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Managing Advanced Prostate Cancer in the Future

Hereditary Prostate Cancer Testing in Practice

Improvements in Detecting and Treating Metastatic CRPC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Developments in the NETs Treatment Landscape

Apalutamide: A Next-Gen Agent for Nonmetastatic CRPC

The Value of AR-Targeted Therapy in CRPC

Understanding Nonmetastatic CRPC: An Overview

Prostate Cancer: Advice for Oncologists on AR-V7 Testing

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Redefining Advanced Prostate Cancer with Novel Imaging

Raoul S. Concepcion, MD, FACS, moderates this discussion with Daniel George, MD; Alec Koo, MD; Phillip Koo, MD; and Neal Shore, MD, FACS. The group of urologists and oncologists specializing in prostate cancer discusses redefining advanced prostate cancer with novel imaging.
View Now

Metastatic Prostate Cancer Update

Charles Ryan, MD, describes his approach to use of androgen receptor-targeted therapy for the treatment of castration-resistant prostate cancer. Dr. Ryan provides additional perspective on the topic of predictive markers.
View Now

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approvals of HPV Vaccine and NGS Assay, Priority Review in Myeloma, and More